Suven Life Sciences Ltd.

NSE: SUVEN | BSE: 530239 | ISIN: INE495B01038 | Industry: Healthcare Services
|
224.8200 -7.48 (-3.22%)
NSE Sep 23, 2025 15:31 PM
Volume: 177.5K
 

224.82
-3.22%
Geojit BNP Paribas
High emphasis on R&D; to provide long term stability while entry to formulations will bring margin benefits in future. CRAMS to provide steady revenue growth with 116+ active projects while a promising NCE (New Chemical Entity) pipeline of 13 molecules to drive the momentum....
Suven Life Sciences Ltd. is trading above its 200 day SMA of 180.5
More from Suven Life Sciences Ltd.
Recommended